Brian Druker, M.D., to Keynote Event Honoring Jeffrey Sachs, Barry Bloom NEW YORK, Sept.

Oregon Health & Science University today announced that Philip H. and Penny Knight have pledged to give $100 million to the OHSU Cancer Institute.

By Doussard, Robin; Hyatt, Abraham; Lee, Eunice; Matschek, Brooke; Et al WHEN THE CANCER DRUG GLEEVEC, used to treat a particular kind of leukemia, got the green light from the Food and Drug Administration in 2001, it heralded a new age in cancer treatment. Dr.

The drug Gleevec has been shown to improve outcomes for children with Philadelphia chromosome-positive acute lymphoblastic leukemia. Dr.

By The Columbian, Vancouver, Wash. Oct. 1--A cancer-fighting drug featured in a story in Sunday's The Columbian has extended the lives of a lot of people. But its chemical composition isn't the only aspect of Gleevec that's been a life-extender.